يحاول ذهب - حر

Taiwan's Success Story In Combating Covid-19

May 2020

|

BioSpectrum Asia

COVID-19 has unravelled the potency and the feebleness of most geographical region’s healthcare, technical, social and political structure. While countries are anticipating various dimensions to tackle coronavirus and combat the pandemic, Taiwan’s success in controlling COVID-19 has bolstered its global standing despite the close geographical proximity with China. The resilient island aggregated its forces to tackle the virus and circumstances rationally with well-established pandemic control strategies, bio medical assets, advanced IoT capabilities, impeccable healthcare system and a well organised political force. Taiwan apparently grappled the coronavirus incredibly well and is now keen to offer medical and technical assistance to other countries in this global crisis.

- Hithaishi C Bhaskar 

Taiwan's Success Story In Combating Covid-19

Taiwan, an island state in East Asia is located at less than 150 km sea route away from China, the epicentre of COVID-19 outbreak. Among the 23 million population of the island 850 000 reside-in and 404 000 work in China. Though the world’s corona death tool is steeping with elevated graph, Taiwan has recorded only 429 cases and 6 reported deaths as of April 30, 2020.

Taiwan has always been provident from its earlier lessons learnt during SARS outbreak in 2003. Thus, the country became hyper-vigilant once the first case of mysterious pneumonia reported in Wuhan, China. Taiwan developed its proficient and self-established health system to address any upcoming pandemic or epidemic. Taiwan’s advanced hub is combating COVID-19 through science, technology, and democratic proactive governance and most importantly independent of WHO tracking system. Taiwan believes in strategic pre planning prior to the outbreak and constantly reviews immigration policies as and when the situation evolves to monitor any emerging infectious diseases.

Taiwan’ trajectories and execution strategies in assessing COVID-19 and quick actions in preventing a large-scale epidemic may be instructive for other countries as the virus continue to threaten global health and economies.

Rapid response and effective strategies

Ever since the SARS epidemic in 2003, Taiwan has been on constant alert by establishing public health response mechanism which activates emergency public health management structures. Taiwan proficient teams quickly mobilize and institute specific approaches for case identification, containment, and resource allocation.

المزيد من القصص من BioSpectrum Asia

BioSpectrum Asia

BioSpectrum Asia

Collaborative R&D: Partnerships shaping the future of biopharma

Biotechs and pharma companies face rising costs of drug development, depleting R&D pipelines and diminishing returns on investment. By joining forces and exploring collaborative R&D partnerships it is possible to overcome these challenges. In addition to sharing risks, they share the potential rewards when their assets move further into clinical development or come to the market.

time to read

2 mins

BioSpectrum Asia Sep 2025

BioSpectrum Asia

BioSpectrum Asia

Quantum Computing: Future of diagnostics is being coded today

A silent revolution is being built at the intersection of biology and quantum physics. After decades of pushing the boundaries of diagnostics with advanced imaging and AI, we are now approaching a hard computational wall. For complex conditions like Alzheimer's, Parkinson's, and many cancers, the interacting variables of genomics, proteomics, and real-world patient data are simply too vast for classical computers to master. This limitation caps the ability to move from merely spotting correlations to uncovering true causation. Unlike traditional AI, quantum computing can simulate underlying physical systems to derive precise solutions. The transition from correlational analysis to causal simulation will enable a more valuable and advanced frontier in diagnostics.

time to read

4 mins

BioSpectrum Asia Sep 2025

BioSpectrum Asia

First Pacific woman to serve as public health director in NZ

The Ministry of Health in New Zealand (NZ) has appointed Dr Corina Grey as the new Director of Public Health this year, a landmark appointment for Pacific leadership.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

Bio-Rad appoints Rajat Mehta as Executive Vice President of Global Commercial Operations

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, has announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial Operations, effective August 4, 2025.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

BioSpectrum Asia

Hugel launches botulinum toxin Letybo in Malaysia

South Korea-based Hugel Inc., a leading global medical aesthetics company, has officially launched its botulinum toxin product Letybo in Malaysia - an emerging market for medical aesthetics in Southeast Asia.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

BioSpectrum Asia

Australia designs smart wound monitor to improve chronic infection care

Researchers from Australia's RMIT University have developed a wearable wound monitoring device with integrated sensors that could reduce infection risks by minimising the need for frequent physical contact.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

Revvity unveils innovative reagent technology to accelerate therapeutics development

US-based Revvity, Inc. has announced the launch of pHSense reagents, a powerful technology designed to advance internalisation studies in drug discovery.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

BioSpectrum Asia

Sanofi acquires next-gen vaccine biotech Vicebio for $1.6 B

Vicebio, a biopharmaceutical company with operations in Australia, UK and Belgium, has entered an exclusive, definitive agreement to be acquired by Sanofi.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

HOSMAC signs MoU with Gulf Medical University to strengthen healthcare education

HOSMAC, Asia's leading hospital planning, design, and management consultancy, has signed a Memorandum of Understanding (MoU) with Gulf Medical University (GMU), Ajman, UAE, to serve as an industry partner.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

Jessica Cowden takes charge as Deputy Director General of CARE unit at IVI

Dr Jessica Cowden has been appointed Deputy Director General of the Clinical, Assessment, Regulatory, Evaluation (CARE) unit at South Korea-headquartered International Vaccine Institute (IVI). She will continue to be based at IVI's Europe Regional Office in Stockholm, Sweden.

time to read

1 min

BioSpectrum Asia Sep 2025

Translate

Share

-
+

Change font size